Comparison between Safety Controls IPO and Sheel Biotech IPO.
Safety Controls IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Safety Controls IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Safety Controls IPO is up to ₹45.57 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of Safety Controls IPO is and of Sheel Biotech IPO is ₹63.00 per share.
| Safety Controls IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | ₹59.00 per share |
| Issue Price (Upper) | ₹80.00 per share | ₹63.00 per share |
| Issue Price (Final) | ₹63.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 2000 shares |
| Fresh Issue Size | 56,96,000 shares | 51,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹45.57 Cr | up to ₹32.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 56,96,000 shares | 51,28,000 shares |
| Issue Size Total (Amount) | up to ₹45.57 Cr | up to ₹32.31 Cr |
Safety Controls IPO opens on Apr 06, 2026, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of Safety Controls IPO and Sheel Biotech IPO is Apr 08, 2026, and Oct 03, 2025, respectively.
| Safety Controls IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Apr 02, 2026 | Sep 29, 2025 |
| Issue Open | Apr 06, 2026 | Sep 30, 2025 |
| Issue Close | Apr 08, 2026 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | Apr 09, 2026 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | Apr 10, 2026 | Oct 07, 2025 |
| Credit of Share (Tentative) | Apr 10, 2026 | Oct 07, 2025 |
| Listing date (Tentative) | Apr 13, 2026 | Oct 08, 2025 |
| Anchor Lockin End date 1 | May 09, 2026 | Nov 05, 2025 |
| Anchor Lockin End date 2 | Jul 08, 2026 | Jan 04, 2026 |
Safety Controls IPO P/E ratio is 12.3, as compared to Sheel Biotech IPO P/E ratio of 8.86.
| Safety Controls IPO | Sheel Biotech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.53 | 96.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 46.40 | 71.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.3 | 8.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹158.62 Cr. | ₹128.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.14 | 13.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.39 | 16.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.80 | 0.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.50 | ₹7.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.32 | 13.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Safety Controls IPO Retail Individual Investors (RII) are offered 20,48,000 shares while in Sheel Biotech IPO retail investors are offered 20,48,000 shares. Qualified Institutional Buyers (QIB) are offered 12,00,000 shares in Safety Controls IPO and 10,26,000 shares in Sheel Biotech IPO.
| Safety Controls IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,84,000 shares | 15,24,000 shares |
| Market Maker Reservation | 3,04,000 shares | 2,72,000 shares |
| QIB | 12,00,000 shares | 10,26,000 shares |
| NII | 8,64,000 shares | 7,74,000 shares |
| RII | 20,48,000 shares | 18,04,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 56,96,000 shares | 51,28,000 shares |
Safety Controls IPO subscribed 1.28x in total, whereas Sheel Biotech IPO subscribed 15.97x.
| Safety Controls IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 1.31x | 19.73x |
| NII (times) | 2.45x | 25.92x |
| Big NII (times) | 3.37x | 31.64x |
| Small NII (times) | 0.61x | 14.49x |
| RII (times) | 0.76x | 9.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.28x | 15.97x |
